Observational studyHaematologica2018

Ibrutinib does not affect ristocetin-induced platelet aggregation evaluated by light transmission aggregometry in chronic lymphocytic leukemia patients.

Maria Adele Alberelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.